- 全部删除
- 您的购物车当前为空
YHO-13177 是高活性乳腺癌耐药蛋白多药转运通道(BCRP)抑制剂,可增强SN-38活性。
为众多的药物研发团队赋能,
让新药发现更简单!
YHO-13177 是高活性乳腺癌耐药蛋白多药转运通道(BCRP)抑制剂,可增强SN-38活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 295 | In stock | |
5 mg | ¥ 712 | In stock | |
10 mg | ¥ 1,130 | In stock | |
25 mg | ¥ 1,980 | In stock | |
50 mg | ¥ 2,950 | In stock | |
100 mg | ¥ 4,260 | In stock | |
200 mg | ¥ 6,070 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 578 | In stock |
YHO-13177 相关产品
产品描述 | YHO-13177 is a potent and specific inhibitor of BCRP; potentiated the cytotoxicity of SN-38 in cancer cells and no effect on P-glycoprotein–mediated paclitaxel resistance in MDR1-transduced human leukemia K562 cells. |
别名 | YHO13177, YHO 13177 |
分子量 | 370.47 |
分子式 | C20H22N2O3S |
CAS No. | 912287-56-0 |
Smiles | COc1ccc(cc1OC)C(=C\c1ccc(s1)N1CCC(O)CC1)\C#N |
密度 | 1.266 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (121.47 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容